Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Imogene Grimes"'
Publikováno v:
Drug Information Journal. 46:593-599
The use of a single central laboratory with universal references ranges is not always a viable option in clinical studies; examples are oncology studies where a rapid turnaround of clinical laboratory results is critical. However, the complexities as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f45691879f9dd102e856b0de489593e7
https://doi.org/10.1177/0092861512446333
https://doi.org/10.1177/0092861512446333
Autor:
Paul S. Aisen, Marwan N. Sabbagh, Adnan M M Mjalli, Douglas Galasko, Aaron H Burstein, Imogene Grimes
Publikováno v:
BMC Neurology
Background TTP488, an antagonist at the Receptor for Advanced Glycation End products, was evaluated as a potential treatment for patients with mild-to-moderate Alzheimer’s disease (AD). A previous report describes decreased decline in ADAS-cog (del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d575970ffd575514fcfcbae2d5d8f4df
https://doi.org/10.1186/1471-2377-14-12
https://doi.org/10.1186/1471-2377-14-12
Publikováno v:
The Journal of Clinical Pharmacology. 39:927-933
The authors compare the pharmacokinetic profiles, safety, and tolerability of rabeprazole, a new proton pump inhibitor (PPI), in healthy volunteers and in subjects with stable, end-stage renal failure. This single-center, open-label trial included tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28dd3eae41d33bcc3ad9cd6e860823d5
https://doi.org/10.1177/00912709922008542
https://doi.org/10.1177/00912709922008542
Publikováno v:
Clinical Therapeutics. 21:691-701
This single-center, open-label study was undertaken to compare the tolerability and pharmacokinetic profiles of rabeprazole, a new proton-pump inhibitor (PPI), in healthy volunteers and in subjects with chronic cirrhosis. Thirteen healthy men and 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190421d408d137a1c069ac1ee3e56752
https://doi.org/10.1016/s0149-2918(00)88320-4
https://doi.org/10.1016/s0149-2918(00)88320-4
Autor:
Cesare Orlande, Douglas Galasko, Imogene Grimes, Ronald G. Thomas, David J. Clark, Paul S. Aisen, Adnan M M Mjalli, Aaron H. Burstein
Publikováno v:
Alzheimer's & Dementia. 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108fc2d6344bcf64e3943e832299b6d0
https://doi.org/10.1016/j.jalz.2013.05.558
https://doi.org/10.1016/j.jalz.2013.05.558